|
|
||||||||
Ann Thorac Surg 1993;55:413-419
© 1993 The Society of Thoracic Surgeons
a Georgetown University School of Medicine, Washington, DC USA
b Medical College of Virginia, Richmond, Virginia USA
c Food and Drug Administration, Rockville, Maryland USA
Accepted for publication May 18, 1992.
* Address reprint requests to Dr Hopkins, Department of Surgery, 4PHC, Georgetown University, 3800 Reservoir Rd, NW, Washington, DC 20007.
To assess the initial metabolic phase of cellular injury from cardiac valve processing, high-energy phosphate concentrations were analyzed in valve leaflets subsequent to critical processing steps. Using a porcine model, valves were processed in a manner identical to human homografts, with 58 randomly assigned to five groups representing distinct preparation phases. Group I (controls) sustained 40 minutes of warm ischemia concluded by liquid nitrogen immersion. Remaining groups similarly endured 40 minutes of ischemia, but were subsequently prepared according to stepwise design: II, warm ischemia + 24 hours of 4 °C ischemia; III, warm ischemia + 24 hours of 4 °C antibiotic disinfection; IV, warm ischemia + 24 hours at 4 °C (without antibiotics) + cryopreservation (–1 °C/min cryoprotected freezing); and V, warm ischemia + disinfection + cryopreservation. At each regimen's conclusion leaflet extracts were assayed by high-performance liquid chromatography for high-energy adenine nucleotides (adenosine triphosphate, adenosine diphosphate, adenosine monophosphate) and catabolites. A 47% and 86% decrease in cellular adenosine triphosphate level was observed in group III and group V leaflets, respectively. The level of total adenine nucleotides was maintained up to cryopreservation; thereafter a 74% decrease was noted. Catabolite analysis confirmed incomplete degradation of adenine nudeotides indicating cellular metabolic resilience throughout standard homograft preparation in valves previously exposed to 40 minutes of warm ischemia.
This article has been cited by other articles:
![]() |
H. J. Geissler, U. M. Fischer, S. Foerster, A. Krahwinkel, A. Antonyan, A. Kroener, K. Addicks, U. Mehlhorn, and W. Bloch Effect of Thawing on Nitric Oxide Synthase III and Apoptotic Markers in Cryopreserved Human Allografts Ann. Thorac. Surg., November 1, 2006; 82(5): 1742 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Raanani, T. M. Yau, T. E. David, G. Dellgren, B. D. Sonnenberg, and A. Omran Risk factors for late pulmonary homograft stenosis after the Ross procedure Ann. Thorac. Surg., December 1, 2000; 70(6): 1953 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Messier Jr, B. L. Bass, P. W. Domkowski, and R. A. Hopkins INTERSTITIAL CELLULAR AND MATRIX RESTORATION OF CARDIAC VALVES AFTERCRYOPRESERVATION J. Thorac. Cardiovasc. Surg., July 1, 1999; 118(1): 36 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Hilbert, R. E. Luna, J. Zhang, Y. Wang, R. A. Hopkins, Z.-X. Yu, and V. J. Ferrans ALLOGRAFT HEART VALVES: THE ROLE OF APOPTOSIS-MEDIATED CELL LOSS J. Thorac. Cardiovasc. Surg., March 1, 1999; 117(3): 454 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Neves, S. Gulbenkian, T. Ramos, A. P. Martins, M. C. Caldas, R. Mascarenhas, M. Guerreiro, A. Matoso-Ferreira, R. Santos, C. Monteiro, et al. MECHANISMS UNDERLYING DEGENERATION OF CRYOPRESERVED VASCULAR HOMOGRAFTS J. Thorac. Cardiovasc. Surg., June 1, 1997; 113(6): 1014 - 1021. [Abstract] [Full Text] |
||||
![]() |
C. Wassenaar, W. A. Bax, R.-J. van Suylen, V. D. Vuzevski, and E. Bos EFFECTS OF CRYOPRESERVATION ON CONTRACTILE PROPERTIES OF PORCINE ISOLATED AORTIC VALVE LEAFLETS AND AORTIC WALL J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 165 - 172. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |